Patients at risk as UK plans to leave Euratom
The UK's proposed withdrawal from Euratom may threaten the supply of essential medical isotopes, putting cancer patients at risk...
List view / Grid view
News
Uncovering the cause of immunotherapy resistance in tumours
Scientists have uncovered a key factor in the development of immunotherapy resistance in the case of cutaneous melanoma. This could potentially lead to future improvements in cancer therapy.
Double network hydrogels make drug-releasing systems safer
Double network hydrogel composed of two interwoven polymer nets to improve the safety of drug-delivery systems that reside within the stomach...
US ophthalmic drugs market set to pass $34bn by 2025
Major market players across the US are upping investments in research to innovate on treatment methods and improve ophthalmic drugs action...
Influenza virus mutations prevented during vaccine production
Duke researchers used a bivalent virus from chicken cells that packaged twice as much protein as a monovalent virus, and vaccinated mice with either the bivalent or monovalent vaccine
Growth in next-generation sequencing informatics market fuelled by big data
Report predicts strong demand from biopharma will encourage NGS informatics providers to deliver customised solutions
Gilead’s fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability
Phase 3 trials of Gilead’s fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability and low resistance
UK bioscience companies form Rare Disease Industry Group
The BIA is committed ensuring patient access to treatments for rare and very rare conditions, sometimes referred to as orphan and ultra-orphan medicines...
Future has “never been brighter” for US biopharmaceuticals
PhRMA report highlights the healthy nature of the US biopharmaceuticals industry, which invests about $75bn annually in research and development and supports nearly 4.7m jobs across the country
Low-cost drugs package saves lives of people starting HIV treatment late
Treating people who start HIV treatment late with a package of low-cost drugs to prevent serious infections saves three lives for ...
NICE publishes new Parkinson’s clinical guidance
Parkinson’s disease is one of the most common neurological conditions, affecting an estimated 130,000 people in the UK, with an annual incidence of around 15-20 per 100,000. It mainly affects people aged 50 or over.
FDA clears first neonatal magnetic resonance imaging device
Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU)...
ISPE updates guidance on risk-based manufacturing
New ISPE guidance provides a scientific, risk-based approach for managing cross-contamination risk within shared facilities ...
Robots and carbon targets may signal the end of globalisation
Automation and 3D printing to environmental regulations are now spelling the beginning of the end for globalised manufacturing...
Codes of ethics cause problems for overseas operations
Corporate codes of ethics can have reverse effects and mask anomalies or social evils in operations outsourced to low-wage countries...
